Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico

PLoS One. 2016 Jan 7;11(1):e0146258. doi: 10.1371/journal.pone.0146258. eCollection 2016.

Abstract

Aim: To analyze the genetic heterogeneity of the Amerindian and admixed population (Mestizos) based on the IL28B (rs12979860, rs8099917) and IFNL4 (rs368234815) haplotypes, and their association with spontaneous clearance (SC) and liver damage in patients with hepatitis C infection from West Mexico.

Methods: A total of 711 subjects from West Mexico (181 Amerindians and 530 Mestizos) were studied for the prevalence of IL28B (rs12979860C/T, rs8099917G/T) and IFNL4 (rs368234815∆G/TT) genotypes. A case-control study was performed in 234 treatment-naïve HCV Mestizos (149 chronic hepatitis C and 85 with SC) for the association of haplotypes with SC and liver damage. A real-time PCR assay was used for genotyping, and transitional elastography staged liver damage.

Results: Significant Fst-values indicated differentiation between the studied populations. The frequencies of the protective C, T, TT alleles were significantly lower in the Amerindians than in Mestizos (p<0.05). The r2 measure of linkage disequilibrium was significant for all variants and the T/G/ΔG risk haplotype predominated in Amerindians and secondly in Mestizos. The protective C/T/TT haplotype was associated with SC (OR = 0.46, 95% IC 0.22-0.95, p = 0.03) and less liver damage (OR = 0.32, 95% IC 0.10-0.97, p = 0.04) in chronic patients. The Structure software analysis demonstrated no significant differences in ancestry among SC and chronic patients.

Conclusions: West Mexico's population is genetically heterogeneous at the IL28B/IFNL4 polymorphisms. The T/G/ΔG high-risk haplotype predominated in Amerindians and the beneficial alternative haplotype in Mestizos. The C/T/TT haplotype was associated with SC and less liver damage in chronically infected Mestizo patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Case-Control Studies
  • Female
  • Gene Expression / immunology
  • Gene Frequency
  • Haplotypes
  • Hepacivirus / immunology*
  • Hepatitis C, Chronic / ethnology
  • Hepatitis C, Chronic / genetics*
  • Hepatitis C, Chronic / immunology
  • Hepatitis C, Chronic / virology
  • Humans
  • Indians, North American*
  • Interferons
  • Interleukins / genetics*
  • Interleukins / immunology
  • Liver / immunology
  • Liver / virology
  • Male
  • Mexico / epidemiology
  • Middle Aged
  • Remission, Spontaneous

Substances

  • interferon-lambda, human
  • IFNL4 protein, human
  • Interleukins
  • Interferons

Grants and funding

The study was supported by Promep-University of Guadalajara (UDG-CA-478) to AP and by the São Paulo Research Foundation (FAPESP)/Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (Grant 2010/10549-1) and the Hospital Israelita Albert Einstein, São Paulo, Brasil to JRRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.